
InMode Without Vasculaze Operator Manual
Section 8: Lumecca Treatment
Information
49 of 96
Vitiligo.
Skin type V and VI and excessively tanned skin from sun, tanning beds or tanning
creams and sprays within the last two weeks.
As per the practitioner's discretion, refrain from treating any condition which might
make it unsafe for the patient.
Do not treat the upper eyelids and the lips!
Do not treat over tattoo and permanent makeup!
Permanent hair reduction may occur in the treated area.
Do not treat over an area with a high density of hair. Absorption of light by
hair follicles may cause an adverse skin reaction.
2.1
Possible Adverse Effects
Possible adverse effects include but are not limited by: discomfort or pain, excessive
skin redness (erythema) and/or swelling (edema), damage to natural skin texture
(crust, blister, and burn), change of pigmentation (hyper- and hypo-pigmentation),
and scarring.
Erythema, lasting not longer than 24h is a typical skin reaction to the Lumecca
treatment.
The patient must understand the importance of pre-treatment and post-treatment
instructions and that failure to comply with these instructions may increase the
probability of complications.
2.1
Pre-Treatment
During the patient’s first visit the treating attendant should:
Complete or update the patient's medical and physical history.
Exclude from treatment anyone with the listed contraindications.
Determine why the patient is seeking treatment and what his/her expectations
are.
Inform the patient about treatment arrangement, typical treatment results and
possible side effects and discomfort.